(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DIA Global Center

Nov 04, 2019 8:15 AM - Nov 05, 2019 4:45 PM

21 Dupont Circle NW, Suite 300, Washington, DC 20036

Safety Risk Communication for Medical Products

Learn how to enhance the effectiveness of safety risk communication in light of evolving regulatory expectations by attending this course.

Register

Back to Agenda

Session 11: Risk Communication: Evaluating Effectiveness

Session Chair(s)

Meredith Yearsley Smith, PHD, MPA, FISPE

Meredith Yearsley Smith, PHD, MPA, FISPE

Fellow and faculty member

USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States

    Regulatory authorities now require companies to assess the effectiveness of risk communication initiatives implemented as part of formal risk minimization commitments. This session will familiarize participants with the key challenges involved in evaluating risk communication initiatives and available methods for doing so.

Have an account?

Register

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.